Clinical implications of epidermal growth factor receptor (EGFR) epigenetic modification in lung cancer, proof of concept for dual multitargeted epigenetic therapy (MTET) in combination with egfr inhibitors
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.